Alzheimer's drug trials take heat

The conduct of Alzheimer's researchers in clinical trials has come under question, with revelations the results of genetic testing were withheld from participants which throws doubt on whether their consent was truly informed.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here